Analysis reveals mutational signatures across periods in lung adenocarcinoma, suggesting evolutionary patterns in Chinese patients.
The proportion of different mutational signatures that underlie the non-clustered, Omikli, and other mutations over different mutation periods.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: